Reversing resistance to antiandrogens with a histone deacetylase inhibitor

Oncotarget. 2018 Dec 18;9(99):37284-37285. doi: 10.18632/oncotarget.26464.

Author

Anna C Ferrari¹

Affiliation

¹ Anna C. Ferrari: Visiting Professor, Division of Medical Oncology, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY, USA.

No abstract available

Keywords: antiandrogen; castration resistant; histone deacetylase inhibitor; prostate cancer; resistance reversion.

Publication types

Editorial